ELEVATION ONCOLOGY INC (ELEV) Stock Analyst Earnings Estimates
NASDAQ:ELEV - Nasdaq - US28623U1016 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A 378.69% | N/A 172.04% | N/A 68.71% | N/A 36.76% | N/A 10.49% | ||||||
| EBITDA YoY % growth | -5.88M | -17.26M -193.54% | -32.03M -85.57% | -94.52M -195.10% | -40.299M 57.36% | N/A -153.11% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -5.88M | -17.28M -193.88% | -32.05M -85.47% | -94.55M -195.01% | -40.338M 57.34% | N/A -19.41% | N/A -29.34% | N/A -35.00% | N/A -34.39% | N/A 34.61% | N/A 96.09% | N/A 1,806.62% | N/A 161.78% | N/A 64.04% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -4.09 -63.80% | -1.53 62.59% | N/A 43.08% | N/A -6.24% | N/A -7.42% | N/A -4.95% | N/A 24.69% | N/A 84.74% | N/A 348.94% | N/A 184.89% | N/A 145.61% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.23 -19.45% | -0.24 -4.88% | -0.23 -27.64% | -0.23 -2.70% | -0.24 -4.21% | -0.26 -5.71% | -0.27 -17.65% | -0.28 -21.90% | -0.28 -18.61% | -0.35 -36.00% | -0.35 -28.30% | -0.36 -29.63% |
| Revenue Q2Q % growth | N/A | N/A | N/A | |||||||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -13.411M -68.78% | -14.283M -44.72% | -15.425M -40.70% | -16.617M -25.61% | -17.922M -33.64% | -17.544M -22.83% | -19.788M -28.29% | -21.216M -27.68% | -22.644M -26.35% | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.22 12.00% | -0.20 | -0.02 | -8.46% |
| Q2 2024 Q2Q % growth | -0.18 51.35% | -0.23 | 0.05 | 21.12% |
| Q1 2024 Q2Q % growth | -0.23 68.06% | -0.21 | -0.02 | -11.52% |
| Q4 2023 Q2Q % growth | -0.19 76.83% | -0.24 | 0.05 | 21.54% |
| Q3 2023 Q2Q % growth | -0.25 85.03% | -0.33 | 0.08 | 23.41% |
| Q2 2023 Q2Q % growth | -0.37 56.98% | -0.33 | -0.04 | -12.77% |
| Q1 2023 Q2Q % growth | -0.72 2.70% | -0.60 | -0.12 | -19.30% |
| Q4 2022 Q2Q % growth | -0.82 -100.00% | -0.80 | -0.02 | -2.87% |
| Q3 2022 Q2Q % growth | -1.67 -215.09% | -1.32 | -0.35 | -26.14% |
| Q2 2022 Q2Q % growth | -0.86 82.23% | -0.80 | -0.06 | -7.03% |
| Q1 2022 Q2Q % growth | -0.74 | -0.51 | -0.23 | -44.00% |
| Q4 2021 Q2Q % growth | -0.41 | -0.60 | 0.19 | 31.41% |
| Q3 2021 Q2Q % growth | -0.53 | -0.39 | -0.14 | -35.40% |
| Q2 2021 Q2Q % growth | -4.84 | -2.88 | -1.96 | -68.07% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 3.26% | 3.26% | 0.89% | -1.29% |
| Revenue | N/A | N/A | N/A | N/A |